FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely gastroenterology, and may be used for treating viral hepatites. Treating viral hepatites involves the interferon therapy. An interferon therapy session is conducted by inhalations of a gas mixture of xenon and oxygen in the concentration of 50:50 to observe the signs of gas exposure - faintness, nystagmus, paresthesia, hyperemia of face, euphoria. The gas mixture is inhaled every second day for 1 month.
EFFECT: invention enables reducing the number of therapeutic complications that is ensured by prevention of stress and depression.
4 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING STRESS AND DEVICE FOR IMPLEMENTATION THEREOF | 2012 |
|
RU2524765C1 |
METHOD OF CHRONIC VIRUS HEPATITIS TREATMENT | 2008 |
|
RU2369403C1 |
MEDICATION COMPOSITION AND METHOD OF ITS OBTAINING FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B OR C AND AIDS | 2010 |
|
RU2440133C2 |
METHOD OF INHALATION AND DEVICE FOR IMPLEMENTATION THEREOF | 2008 |
|
RU2436602C2 |
METHOD FOR TREATMENT OF CHRONIC HEPATITIS | 2005 |
|
RU2286792C1 |
METHOD FOR REHABILITATION OF POST-VIRAL INJURIES OF LUNG PARENCHYMA AND DEVICE FOR ITS IMPLEMENTATION | 2020 |
|
RU2752856C1 |
METHOD FOR IMMUNE THERAPY OF VIRAL HEPATITIS C | 2013 |
|
RU2523386C1 |
METHOD AND DEVICE FOR INHALATION | 2006 |
|
RU2317112C1 |
METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
METHOD FOR DETERMINING THE RISK OF HEPATOCELLULAR CARCINOMA IN THE PATIENTS WITH CHRONIC HEPATITIS C | 2019 |
|
RU2723891C1 |
Authors
Dates
2013-08-10—Published
2012-05-31—Filed